Gold, L. S.; Lebwohl, M. G.; Bhatia, N.; Lin, T.; Pillai, R. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion. J of Skin 2019, 3, S31.